A new generative AI model trained on UK Biobank data predicts risks for over 1,000 diseases up to 20 years in advance, leveraging lifestyle and health records to enable early preventive interventions. Additional biotech startups use AI-enabled foundation models to accelerate drug discovery by simulating transcriptomic data and predicting experimental results. These advances demonstrate AI's growing role in precision medicine and biomedical research, with applications from diagnostics to therapeutic target identification.